Cardiovascular Check

An advanced cardiovascular risk panel with 10 biomarkers including lipoprotein(a) and high-sensitivity CRP alongside the standard lipid profile and HbA1c. Lp(a) is a genetically determined risk factor that standard cholesterol testing does not capture, affecting approximately one in five people. Combined with hs-CRP for vascular inflammation and HbA1c for three-month glucose control, this panel delivers a thorough heart disease risk assessment at the Labor Staber Munich facility.

Standard lipid panels measure cholesterol fractions and triglycerides but miss important independent risk factors. This cardiovascular panel addresses two significant gaps. Lipoprotein(a) is a genetically inherited lipoprotein particle that promotes atherosclerosis and thrombosis independently of LDL cholesterol. Because Lp(a) levels are determined almost entirely by genetics and remain stable throughout life, a single measurement provides permanent risk stratification information. High-sensitivity CRP measures low-grade systemic inflammation within arterial walls, a process central to plaque development and rupture. Elevated hs-CRP predicts cardiovascular events even when cholesterol levels appear normal, making it a valuable complement to traditional lipid testing. HbA1c captures average blood glucose over the preceding three months, identifying pre-diabetic glucose dysregulation that accelerates vascular damage long before a diabetes diagnosis. The panel also includes a complete blood count, fasting glucose, standard lipid fractions, and creatinine for kidney function. This combination enables risk stratification that goes well beyond what a routine cholesterol check provides, making it particularly relevant for anyone with a family history of early heart disease. All results are typically available the same day. A 10-12 hour fast is required for accurate lipid and glucose values.